Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.14 USD
Change Today +0.02 / 0.22%
Volume 142.1K
STAA On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GM
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

staar surgical co (STAA) Snapshot

Open
$9.17
Previous Close
$9.12
Day High
$9.34
Day Low
$9.03
52 Week High
04/25/14 - $19.60
52 Week Low
01/27/15 - $4.84
Market Cap
354.6M
Average Volume 10 Days
182.7K
EPS TTM
$-0.21
Shares Outstanding
38.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for STAAR SURGICAL CO (STAA)

Related News

No related news articles were found.

staar surgical co (STAA) Related Businessweek News

No Related Businessweek News Found

staar surgical co (STAA) Details

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. The company offers implantable collamer lenses (ICL) comprising Visian ICL to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also provides invasive intraocular lenses (IOL) that include aspheric IOLs that produce a clearer image than traditional spherical lenses; nanoFLEX IOL, a single piece collamer aspheric optic; Toric IOL for cataract patients to treat pre-existing astigmatism; and Preloaded Injector, a silicone or acrylic IOL preloaded into a single-use disposable injector. In addition, the company sells surgical products, and other related instruments and devices; and manufactures AquaFlow device for the treatment of glaucoma. It markets its products to health care providers, including surgical centers, hospitals, managed care providers, health maintenance organizations, group purchasing organizations, and government facilities. The company offers its products primarily under the STAAR, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, Epiphany, and AquaFlow names. It sells products directly through its sales representatives in the United States, Canada, Japan, and Spain, as well as through independent distributors in approximately 60 countries worldwide. STAAR Surgical Company was founded in 1982 and is headquartered in Monrovia, California.

300 Employees
Last Reported Date: 03/13/15
Founded in 1982

staar surgical co (STAA) Top Compensated Officers

Chief Financial Officer and Vice President
Total Annual Compensation: $122.0K
Vice President, Corporate Compliance Officer,...
Total Annual Compensation: $377.4K
Chief Accounting Officer and Vice President
Total Annual Compensation: $334.4K
Vice President of Global Research & Developme...
Total Annual Compensation: $366.7K
Vice President of Global Marketing
Total Annual Compensation: $324.6K
Compensation as of Fiscal Year 2013.

staar surgical co (STAA) Key Developments

STAAR Surgical Company Appoints J. Steven Roush to its Board

STAAR Surgical Company announced that its Board of Directors has appointed J. Steven Roush, CPA to the company's Board. Mr. Roush brings an important combination of financial regulatory and reporting agencies expertise, largely gained over a 39 year tenure as a Partner at PricewaterhouseCoopers, prior to his retirement in 2007. He is currently a member of the Board and Chairman of the Audit Committee for Summit Healthcare REIT. Currently, Mr. Roush is also a Board Member of Air Touch Communications and WE Hall Company.

STAAR Surgical Company Appoints Hans Blickensdoerfer as President of International Commercial Operations

STAAR Surgical Company has named Hans Blickensdoerfer to the newly created position of President, International Commercial Operations. Mr. Blickensdoerfer joined STAAR in January 2005 and most recently served as President of Europe, Middle East and Latin America. Prior to joining STAAR, Mr. Blickensdoerfer was Vice President of Sales and Marketing for Milvella Ltd., where his duties included both regional and worldwide business planning, product launches and management of European clinical studies.

STAAR Surgical Company Announces Executive Changes

STAAR Surgical Company has named Caren Mason as President and Chief Executive Officer effective immediately. Ms. Mason, who was elected to STAAR's Board of Directors in June 2014, and was appointed by the Board to chair the Quality and Regulatory Committee in September 2014, replaces Barry G. Caldwell who retired as of March 1, 2015. Ms. Mason joins STAAR after most recently serving as CEO of, and then advisor to, Verinta Health. Previously, she served as President & CEO of publicly traded Quidel Corporation between 2004 and 2009.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STAA:US $9.14 USD +0.02

STAA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Antares Pharma Inc $2.72 USD -0.04
Biolase Inc $2.17 USD +0.01
Cerus Corp $4.79 USD +0.205
Cutera Inc $14.04 USD +0.13
SurModics Inc $26.53 USD +0.03
View Industry Companies
 

Industry Analysis

STAA

Industry Average

Valuation STAA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.7x
Price/Book 9.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STAAR SURGICAL CO, please visit www.staar.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.